tbuckley/cabot-search huggingface dataset:
Amphetamine Sulfate and Performance
Authors: William G. Cochran
Journal: JAMA (1961)

THE COMMENTS by Dr. Pierson, concerning our work with athletes (as cited previously), represent a remarkable demonstration of misunderstanding and misrepresentation of published findings. Most of his critique is devoted to the question of whether the data reported in the first of our 3 papers justify the conclusion that amphetamine improved the performance of the athletes we studied. His conclusion is that "none of the 6 experiments demonstrated differences between placebo and amphetamine performances which could not be attributed to chance, i.e., a probability of 0.01 or less. They [Smith and Beecher] have thus presented no evidence that a 'true' difference does exist, and conclusions to that effect are not justified by the data." The facts are that 57 athletes were tested. They performed after receiving placebo and after receiving amphetamine sulfate (14 mg. per 70 kg. of body weight). Their scores are presented in the table. A plus
Mental Subnormality
Authors: Hilda Knobloch, Benjamin Pasamanick
Journal: New England Journal of Medicine (1962)

Prenatal NutritionIf protein is important in the phenomena described in the previous section, there should be evidence of its effect in altering the percentage of abnormalities during pregnancy. Reference has already been made to the fact that protein and vitamin supplementation of the diet decreased the incidence of toxemia and premature separation of the placenta. The same investigators112 studied the effects of dietary supplements on the prematurity rates. The clearest effect was seen in infants whose birth weights were less than 2495 gm. (5 1/2 pounds) and gestation periods less than thirty-nine weeks. If the diet was supplemented with . . .
Author's reply
Authors: M. Erlewyn-Lajeunesse
Journal: BMJ (2009)

<h3>ABSTRACT</h3> Individual behavioral variation is common, yet often we do not know how it is maintained. A potential explanation is that some behaviors must be acquired rather than genetically inherited. We investigate the social transmission of behavioral innovations, which can be key for the success of predator species, especially in contexts where environmental changes take place. We examine innovation in two classic predator-prey models. We assume that innovations increase predator attack rates or conversion efficiencies, or that innovations reduce predator mortality or prey handling time. We find that a common outcome of innovations is the destabilization of the system. Destabilizing effects include increasing oscillations or limit cycles. If either of these outcomes increases the risk of extinction, innovations that benefit individual predators may not have positive long-term effects on predator populations. Furthermore, as populations cycle, innovative individuals can be nearly eliminated, maintaining temporal behavioral variability. The destabilizing effects of behavioral innovations on predator-prey dynamics could have implications for biological invasions, urban populations, endangered species, and, more broadly, the maintenance of behavioral polymorphisms.
Posters
Authors: B. Afessa, J. Ivaškcyičius, S. Vosylius, J. Šipylaite, S. W. Benham, J. Kinsella, R. Fretschner, A. Heininger, B. Kottler, A. Wehrle, S. Nikonov, O. Yakushenko, V. Bajbikov, O. Zhdanov, E. Sulima, N. Pyasetskaya, E. Korol, E. Lelchuk, E. Kashpur, J. Garnacho-Montero, C. Ortiz-Leyba, F. J. Jiménez-Jiménez, M. D. Fernández-Vega, C. Pérez-Paredes, J. L. Garcia-Garmendia, B. Vangerow, H. Rueckoldt, G. Marx, M. Jankowski, S. Piepenbrock
Journal: Intensive Care Medicine (1996)
GOVERNMENT SERVICES
Journal: JAMA (1961)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Kartagener's syndrome with normal spermatozoa
Authors: I. Samuel
Journal: JAMA (1987)

<h3>To the Editor.—</h3> Kartagener's syndrome (chronic sinopulmonary symptoms and situs inversus) was shown to be a part of the immotile-cilia syndrome (chronic sinopulmonary symptoms and male sterility) when Afzelius and coworkers demonstrated that males with the immotile-cilia syndrome had immotile (or dysmotile) respiratory cilia and spermatozoa and that 50% of cases of the immotile-cilia syndrome had situs inversus.<sup>1,2</sup>The immotility is attributed to an ultrastructural defect of the respiratory cilium and sperm tail.<sup>1</sup>The inheritance is autosomal recessive. Absence of frontal sinuses is a recognized association.<sup>2</sup> This is to my knowledge the second report of a case of Kartagener's syndrome with normal spermatozoa. The patient had chronic sinopulmonary symptoms, situs inversus, and absent frontal sinuses, while his spermatozoa had normal motility, ultrastructure, and fertilizing capacity. Thus, the entity can be regarded as a new subgroup of the immotile-cilia syndrome. <h3>Report of a Case.—</h3> A bachelor, aged 26
STRUCTURAL AND FUNCTIONAL VARIABILITY OF THE TUMOR B-CELL RECEPTOR INDICATES A ROLE FOR ENVIRONMENTAL INFLUENCES ON BEHAVIOR OF MANTLE CELL LYMPHOMAS
Authors: D. Dutton, G. Chiodin, W. Agata, S. Drennan, I. Henderson, G. Gaidano, P. Johnson, F. Stevenson, G. Packham, B. Sander, F. Forconi
Journal: HemaSphere (2019)
Prospective study of HBV cccDNA kinetics in a French multicenter cohort of liver transplant patients (ECOGREFFE) reveals very early graft infection despite NUC+HBIG prophylaxis
Authors: François Villeret, Fanny Lebossé, Sylvie Radenne, Didier Samuel, Bruno Roche, Ducerf Christian, Jean-Yves Mabrut, Leroy Vincent, Georges-Philippe Pageaux, Rodolphe Anty, Thevenon Sylvie, Françoise Berby, Bordes Isabelle, Caroline Scholtes, Barbara Testoni, Fabien Zoulim
Journal: Journal of Hepatology (2020)
Hamamelis Virginica
Authors: J. V. Shoemaker
Journal: BMJ (1887)

HAMAMELIS VIRGINICA, commonly known as American witch-hazel, has long been employed in the southern and western portion of'the United States as a domestic panacea for all forms of wounds and bruises.Its undoubted haemostatic and anodyne effects, when used in this manner, led very many physicians to test its value both inter- nally and externally.Active Ingredients.-H.K. Bowman states that the bark] contains
CORRESPONDENCE
Authors: ARTHUR WHITFIELD, J. M. H. MACLEOD
Journal: British Journal of Dermatology (1901)

Journal Article CORRESPONDENCE Get access ARTHUR WHITFIELD, ARTHUR WHITFIELD 12, Upper Berkeley Street Search for other works by this author on: Oxford Academic Google Scholar J. M. H. MACLEOD J. M. H. MACLEOD 11, Harley Street, W Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 13, Issue 3, 1 March 1901, Pages 119–120, https://doi.org/10.1111/j.1365-2133.1901.tb16367.x Published: 01 March 1901
Surgery for mitral regurgitation
Authors: L. H. Cohn
Journal: JAMA (1988)

Mitral regurgitation is a valvular heart lesion that is difficult to diagnose accurately; thus, it is difficult to determine the appropriate timing for surgical correction. With increasing use of reparative techniques, including local resection of valve pathology and placement of an annuloplasty ring, and the realization that chronic atrial fibrillation leads to decreased long-term survival, the timing of surgery has changed. In addition, serial noninvasive studies have indicated that despite the absence of symptoms, patients may progress to a myopathic condition if the regurgitation progresses over a long period and surgery is not performed when signs of left ventricular dysfunction are evident. Preservation of the papillary muscle is also extremely important for late postoperative function in patients with mitral regurgitation, and reparative surgery that preserves both anterior and posterior papillary muscle complexes and continuity with the anulus appears to satisfy this assumption. Worldwide experience is reviewed and I present conclusions related to the appropriate indications for mitral valve repair or replacement in patients with mitral regurgitation. (<i>JAMA</i>1988;260:2883-2887)
Postsurgery
Authors: R. B. Horsley
Journal: JAMA (2012)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Informed consent to biomedical research in Veterans Administration Hospitals
Authors: H. W. Riecken
Journal: JAMA (1982)

To illuminate the process of obtaining informed consent to research in a medically dependent population, we interviewed 156 patients and 37 physicians involved in research projects at four Veterans Administration hospitals. Most patients knew they were research subjects, had voluntarily consented, and knew the details of their medical treatment, but few understood the research well. Readability analysis indicated that consent forms required college-level education. Twenty-eight percent of patients were not aware of their participation in research although they had signed consent forms. No single act, omission, or personal attribute completely explains this unawareness, but it is associated with incomplete consent forms, the identity of the person explaining the research, the manner of the explanation, and, in some cases, grave illness. (<i>JAMA</i>1982;248:344-348)
Manual of Medicine.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hereditary Hemochromatosis
Authors: Phillip B. Amidon, Rhonda D. Jankovich
Journal: Annals of Internal Medicine (2001)

Letters18 December 2001Hereditary HemochromatosisPhillip B. Amidon, MD and Rhonda D. Jankovich, RN, BSNPhillip B. Amidon, MDVeterans Administration Medical Center; Togus, ME 04330Search for more papers by this author and Rhonda D. Jankovich, RN, BSNVeterans Administration Medical Center; Togus, ME 04330Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-135-12-200112180-00020 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:We read with interest the findings of Beutler and associates (1), which demonstrated macrocytosis in patients with genetic hemochromatosis. We also noted the presence of macrocytosis in our small group of patients with hemochromatosis.We evaluated a 50-year-old man for possible genetic hemochromatosis. The diagnosis was confirmed by liver biopsy, which documented increased iron staining and elevated hepatic iron and iron index. Our patient's initial complete blood count indicated macrocytosis that increased and then resolved as his iron stores were depleted by multiple phlebotomies. We ascribed this macrocytosis to cirrhosis. When we reviewed the laboratory data on ...Reference1. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med. 2000;133:329-37. [PMID: 0010979877] LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Veterans Administration Medical Center; Togus, ME 04330 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Effect of HFE Genotypes on Measurements of Iron Overload in Patients Attending a Health Appraisal Clinic Ernest Beutler , Vincent Felitti , Terri Gelbart , and Ngoc Ho Hereditary Hemochromatosis Victor Herbert Metrics 18 December 2001Volume 135, Issue 12Page: 1091KeywordsBiopsyCirrhosisHemochromatosisLiverLiver fibrosisMean corpuscular volumePhlebotomyResearch laboratoriesSerum glutamic oxaloacetic transaminaseStaining ePublished: 18 December 2001 Issue Published: 18 December 2001 CopyrightCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
Correction: Bull's Eye: Unraveling the Medical Mystery of Lyme Disease
Journal: JAMA (2004)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A silencer element in the LAMC1 promoter contains two sequences, interacting with the large subunit of replication factor C and SP1, which are involved in laminin ?1 expression in F 567 rat hepatoma cell line Unit� de Recherches H�patologiques, INSERM U-49, CHRU Pontchaillou F-35033 RENNES, and * Laboratory of Developmental Biology, National Institute of Dental Research, Bethesda MD 20892
Journal: Hepatology (1995)
Actual causes of death in the United States
Authors: J. M. McGinnis
Journal: JAMA (1993)

<h3>Objective.</h3> —To identify and quantify the major external (nongenetic) factors that contribute to death in the United States. <h3>Data Sources.</h3> —Articles published between 1977 and 1993 were identified through MEDLINE searches, reference citations, and expert consultation. Government reports and compilations of vital statistics and surveillance data were also obtained. <h3>Study Selection.</h3> —Sources selected were those that were often cited and those that indicated a quantitative assessment of the relative contributions of various factors to mortality and morbidity. <h3>Data Extraction.</h3> —Data used were those for which specific methodological assumptions were stated. A table quantifying the contributions of leading factors was constructed using actual counts, generally accepted estimates, and calculated estimates that were developed by summing various individual estimates and correcting to avoid double counting. For the factors of greatest complexity and uncertainty (diet and activity patterns and toxic agents), a conservative approach was taken by choosing the lower boundaries of the various estimates. <h3>Data Synthesis.</h3> —The most prominent contributors to mortality in the United States in 1990 were tobacco (an estimated 400000 deaths), diet and activity patterns (300 000), alcohol (100 000), microbial agents (90 000), toxic agents (60 000), firearms (35 000), sexual behavior (30 000), motor vehicles (25 000), and illicit use of drugs (20 000). Socioeconomic status and access to medical care are also important contributors, but difficult to quantify independent of the other factors cited. Because the studies reviewed used different approaches to derive estimates, the stated numbers should be viewed as first approximations. <h3>Conclusions.</h3> —Approximately half of all deaths that occurred in 1990 could be attributed to the factors identified. Although no attempt was made to further quantify the impact of these factors on morbidity and quality of life, the public health burden they impose is considerable and offers guidance for shaping health policy priorities. (<i>JAMA</i>. 1993;270:2207-2212)
The torch is passed
Authors: H. S. Jonas
Journal: JAMA (1987)

Back in the 1950s when medical students chose obstetrics and gynecology as a specialty to pursue for residency, it was in part because it was considered a "happy" field of medicine. Patients were young and healthy; they approached parenthood happily, if naively; the outcome usually was joyful. The vigor and stamina of young physicians entering obstetrics was at its peak. The appeal of entering a satisfying career of helping young couples establish their families, followed by a transition of easing more into gynecology as the patient and the physician grew older together, also held a special attraction. What became of that idyllic if simplistic scenario? The Council on Long Range Planning and Development of the American Medical Association has boldly undertaken the task of analyzing the changing environment of medicine so that physicians might get a better perspective on the future and meet the challenge of inevitable change by the
Irradiation Leukemogenesis
Authors: John S. Lawrence
Journal: JAMA (1965)

<h3>To the Editor:—</h3> The expression used in my paper to correspond with a statement made in Dr. Lewis' paper involves the combination of words, "2 × 10<sup>-6</sup>per rad per year." Without previous knowledge or associated context this can be read either (a) (2 × 10<sup>-6</sup>per rad) per year, or (b) 2 × 10<sup>-6</sup>per (rad per year). Avoiding any discussion of the meaning of rem (used by Dr. Lewis for the combined neutron and gamma dose), it is obvious from the context of Dr. Lewis' paper and from my paper that both authors mean the first parenthesization (a), as the rad (or rem) dose refers to an acute dose. The sentence in my paper referred to by Dr. Caretta appears to be based on parenthesization (b) and it seems that no parenthesization would give it a meaning based on (a). The "per year" should be
Incorrect Author's Name in: The JAMA Network Journals: New Names for the Archives Journals
Journal: JAMA (2012)

Howard Bauchner , MD; Daniel M. Albert, MD, MS; Joseph T. Coyle, MD; Julie Ann Freischlag, MD; Wayne F. Larrabee, MD; Paul A. Levine, MD; Rita F. Redberg, MD, MSc; Frederick P. Rivara, MD, MPH; June K. Robinson, MD; Roger N. Rosenberg, MD
PROFESSOR SHERRINGTON'S VISIT.
Journal: JAMA (2003)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Future trends in allergy and clinical immunology
Authors: J. E. Salvaggio
Journal: JAMA (1987)

<h3>RECENT ADVANCES</h3> THE FIELD of allergy and clinical immunology continues to expand rapidly. Since the first edition of the<i>Primer</i>five years ago, advances have been made in virtually all areas of this subspecialty. Immunologic investigations into the pathogenesis of the acquired immunodeficiency syndrome, the experimental application of lymphocyteand macrophage-derived cytokines and other immune response—modifying agents in neoplastic diseases, the development of new anti-inflammatory agents for the treatment of immediate and late-phase hypersensitivity reactions, and the discovery of new mast cell-derived mediators represent only a few of the many advances made during this time. The organ- and disease-oriented approach of the<i>Primer</i>introduces many of these advances in a manner that is appropriate and relevant to students and primary care and specialty practitioners. The approach provides direction for subsequent in-depth analysis of current and future aspects of molecular and cell biology and makes a valuable contribution to understanding the mechanisms